Loperamide: Nursing Drug Guide, Infectious Diarrhea & NCLEX Review

Loperamide is available as prescription capsules and widely as over-the-counter (OTC) tablets, caplets, and oral liquid. Strength is typically 2 mg per capsule or caplet; liquids vary (for example, 1 mg per 7.5 mL in some OTC products). Verify formulation, strength, and whether the product is Rx or OTC on every administration pass.

Common brand names include Imodium, Imodium A-D, and generic loperamide hydrochloride. Combination products with simethicone exist—do not double-count loperamide when both a single-ingredient and combination product are in the home supply.

Per U.S. prescription labeling, loperamide hydrochloride is indicated for control and symptomatic relief of acute nonspecific diarrhea in patients 2 years and older, and of chronic diarrhea in adults associated with inflammatory bowel disease. It is also indicated to reduce discharge volume from ileostomies. OTC labeling limits use to control of diarrhea symptoms including travelers’ diarrhea when appropriate—still subject to the same infection-screening rules.

Loperamide is symptomatic therapy only. When an underlying cause is identified—such as infection, antibiotic-associated colitis, or inflammatory flare—treat the cause; do not rely on antidiarrheal agents alone.

↔On a small screen, swipe or scroll sideways to see the full table.

Loperamide acts on opioid receptors in the gut wall to slow intestinal motility, increase intestinal transit time, reduce daily fecal volume, and increase anal sphincter tone. It is a peripheral mu-opioid agonist with limited central penetration at recommended doses—but systemic exposure rises with overdose, CYP/P-glycoprotein inhibitors, or misuse, increasing CNS and cardiac toxicity risk.

Because motility is reduced, trapped pathogens or toxins in infectious colitis can worsen outcomes—another reason nurses must exclude infectious diarrhea before dosing.

Patients should receive appropriate fluid and electrolyte replacement as needed; loperamide does not replace rehydration therapy. Avoid all doses above recommended limits in adults and children ≥2 years because of serious cardiac adverse reactions.

↔On a small screen, swipe or scroll sideways to see the full table.

Missed dose: Not specified in the reviewed prescribing information for a dedicated missed-dose instruction—do not double doses to catch up; extra doses increase constipation, ileus, and cardiac risk. OTC labeling advises contacting a clinician if diarrhea persists beyond 2 days.

Pretreatment checks

• Complete medication reconciliation—include OTC antidiarrheals and combination cold products
• Confirm age ≥2 years (prescription) and product-specific minimum age for OTC
• Screen stool character: no blood, no black stool, no mucus, and no high fever
• Review recent antibiotics (clindamycin, vancomycin, fluoroquinolones, cephalosporins) for C. difficile risk and possible gastroenteritis
• Assess dehydration, orthostatics, and oral intake; plan IV/oral rehydration when indicated
• Check QT-prolonging medicines and history of arrhythmia; verify abdominal exam for distension and tenderness

Contraindications

• Pediatric patients less than 2 years (respiratory depression and serious cardiac adverse reactions)
• Hypersensitivity to loperamide or excipients
• Abdominal pain in the absence of diarrhea
• Acute dysentery (blood in stools and high fever)
• Acute ulcerative colitis; bacterial enterocolitis from invasive organisms (Salmonella, Shigella, Campylobacter)
• Pseudomembranous colitis (e.g., C. difficile) associated with broad-spectrum antibiotics

Important interactions

↔On a small screen, swipe or scroll sideways to see the full table.

Oral route: Capsules, tablets, caplets, or measured liquid per pharmacy or product directions. Use an oral syringe for liquids—never household spoons.

• Verify 2 mg units and running 24-hour total—include PRN and home doses on the medication record
• Teach patients not to exceed directed doses; OTC heart-alert warnings apply
• Continue oral rehydration unless contraindicated; loperamide is adjunctive
• Chart stool character, fever, and abdominal findings before first inpatient dose

• Fewer unformed stools and improved comfort within about 48 hours for acute diarrhea per labeling
• Controlled chronic stool frequency at the lowest effective maintenance dose
• Stable hydration status with appropriate fluid and electrolyte therapy
• Worsening abdominal pain, distension, or fever while on loperamide suggests hold and reassessment for infection or ileus

Stop loperamide and escalate when any of the following appear:

• Bloody or black stool, mucus, or new high fever—treat as possible infectious or inflammatory colitis
• Abdominal distension, ileus, or toxic megacolon—especially in IBD or immunocompromised patients
• Cardiac toxicity: syncope, palpitations, dizziness with wide QT, Torsades de Pointes, or cardiac arrest—consider overdose or drug interactions
• CNS depression (altered mental status, respiratory depression)—more likely in overdose, hepatic impairment, or young children
• No improvement in acute diarrhea after 48 hours or failure to control chronic diarrhea at maximum labeled dose for 10 days

↔On a small screen, swipe or scroll sideways to see the full table.

Supratherapeutic use (reported chronic ingestions from about 70 mg to 1600 mg daily) has caused life-threatening QT/QTc and QRS prolongation, Torsades de Pointes, Brugada pattern, syncope, cardiac arrest, and death. CNS effects may include altered mental status, somnolence, respiratory depression, hypotension, urinary retention, and paralytic ileus.

Management (labeling)

• Cardiac toxicity: Discontinue loperamide promptly; treat arrhythmias per ACLS and cardiology—antiarrhythmics alone may be ineffective; electrical cardioversion, pacing, or isoproterenol infusion have been reported
• Opioid-type toxicity: Naloxone may reverse CNS and respiratory depression; repeat doses may be needed because loperamide persists in the gut while naloxone is short-acting—monitor ≥24 hours after last naloxone dose
• Admit patients with severe CNS or respiratory depression or repeated naloxone requirements
• Standard opioid drug screens may not detect loperamide

• Loperamide vs diphenoxylate-atropine (Lomotil)—both antidiarrheals; different schedules, atropine content, and controlled-substance rules for Lomotil
• Imodium 2 mg vs combination loperamide/simethicone—risk of double-counting loperamide milligrams
• mg vs number of capsules—initial dose is 4 mg (two capsules), not “4 capsules”
• OTC liquid mL vs mg—use pharmacy oral syringe; confirm mg per mL on label
• Home PRN stacks—patients may add OTC doses to inpatient orders—reconcile 24-hour totals

↔On a small screen, swipe or scroll sideways to see the full table.

↔On a small screen, swipe or scroll sideways to see the full table.

Monitor

• Stool frequency, consistency, and presence of blood or mucus
• Temperature, abdominal exam (distension, tenderness), bowel sounds
• Intake and output, weight, orthostatics, and signs of dehydration
• Heart rate, blood pressure, syncope, palpitations—ECG if cardiac toxicity suspected
• Mental status and respiratory rate—especially in overdose or hepatic impairment
• Running 24-hour loperamide milligram total and concurrent QT-prolonging drugs

Document

• Infection screen (blood, fever, mucus, recent antibiotics) before first dose
• Each dose strength, time, and cumulative daily mg
• Fluid and electrolyte therapy provided
• Hold events, prescriber/pharmacy notifications, and patient teaching on dose limits

• Do not use if you have bloody or black stool, high fever, or mucus in stool—seek care instead
• Never take more than the label or prescriber directs—extra doses can cause serious heart problems
• Drink fluids with electrolytes as directed; this medicine does not replace fluids you lose
• Stop and seek care if diarrhea lasts more than 2 days (OTC), symptoms worsen, or your abdomen swells
• Tell your team about all prescription, OTC, and herbal medicines—especially heart rhythm drugs
• Report fainting, pounding heartbeat, confusion, or trouble breathing immediately
• Keep out of reach of children—overdose can be fatal

Do not give and contact the prescriber or pharmacist when:

Hold parameters may vary by institutional protocol. Follow prescriber orders, pharmacy guidance, and facility policy.

Practice NCLEX-style clinical judgment practice for loperamide with a tabbed case (MAR, labs, I&O, nursing notes) on a patient with antibiotic-associated diarrhea risk, then priority action, infectious-diarrhea cue recognition, deterioration trends, documentation cloze, overdose judgment, and matrix urgency—recognize cues → analyse → prioritise → act → evaluate outcomes.

This medication guide is written and reviewed using NurseOnShift editorial and clinical review standards.

• Editorial Policy
• Medical Review Process
• Disclaimer

Educational use only. This content does not replace clinical judgment, prescriber orders, pharmacist guidance, product labeling, or institutional protocols.